[ad_1]
Spahn shuts off hope for speedy Johnson & Johnson delivery
EU agency recommends Johnson & Johnson vaccine
The European Medicines Agency now also recommends Johnson & Johnson’s corona vaccine. The decisive advantage of the vaccine: only one vaccine is necessary.
“At the earliest in mid to late April”: Health Minister Spahn assumes that the first doses of Johnson & Johnson’s vaccine could not be delivered for a few weeks. The EU Commission is in talks with the manufacturer.
NorthFollowing approval of Johnson & Johnson’s corona vaccine, Federal Health Minister Jens Spahn does not expect deliveries immediately. The CDU politician said Thursday in the ARD “Tagesthemen”: “The truth is that deliveries cannot be expected until mid-April at least, according to Johnson & Johnson.” Now they want to know exactly why other countries would source and if the European Union could participate as soon as possible. The European Commission is conducting the talks.
The vaccine is bottled in the US; There is a de facto export ban for corona vaccines. Spahn said that for the past twelve months one had to experience over and over again that “certain products have not left the United States” with drugs and tests. “I find this problematic, also in terms of being together in the transatlantic partnership.” This should now be discussed with the partners. Now we have to deal with the situation first and make sure there are more productions in Germany and Europe, including the Johnson & Johnson vaccine.
EU Commission approves Johnson & Johnson
The EU Commission approved the corona vaccine from the US company Johnson & Johnson on Thursday. The European Medicines Agency EMA had already given the green light and recommended conditional approval of the vaccine for people over 18 years of age.
Johnson & Johnson’s vaccine is the fourth crown vaccine to receive EU-wide approval after active ingredients from Biontech / Pfizer, Moderna and AstraZeneca. The vaccine is about 85 percent effective against severe Covid 19 illnesses.
A key benefit of the Johnson & Johnson vector virus vaccine is that only one dose is required. It can also be stored at normal refrigerator temperature.
Therefore, the vaccine could significantly speed up vaccination programs in Europe. “With the number of cans ordered, we could vaccinate up to 200 million people in the EU,” said von der Leyen. The EU also has an option for 200 million more doses of the active ingredient.
to show
Buy Antigen Self Tests Online Now
Take a nasal swab, read the result on the test strip within 15 minutes, and find out if you have Covid-19.
However, doubts have already arisen in the EU about whether the US company can deliver on its promises. Johnson & Johnson is expected to deliver 55 million cans by the end of June. However, it was reported in EU circles that the first deliveries were not expected until mid-April at the earliest.
At the end of January, Johnson & Johnson reported a 66 percent effectiveness for the agent in protecting against moderate to severe COVID-19 courses in its global study of about 44,000 participants. To prevent hospitalization, the vaccine was 85 percent effective 14 days after vaccination and 100 percent effective at 28 days. The vaccine is already approved in the US, Canada, and Bahrain.
